Business Description
Astrana Health Inc
NAICS : 621999
SIC : 8099
ISIN : US03763A2078
Share Class Description:
ASTH: Ordinary SharesTotal Employee Number:
3,000Compare
Compare
Traded in other countries / regions
ASTH.USA3AM.Germany Index Membership
Russell 2000Russell 3000 IPO Date
2007-11-26Description
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.45 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 1.33 | |||||
Debt-to-EBITDA | 6.54 | |||||
Interest Coverage | 1.47 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.79 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 37 | |||||
3-Year EBITDA Growth Rate | 3.7 | |||||
3-Year EPS without NRI Growth Rate | 17.4 | |||||
3-Year FCF Growth Rate | 17.7 | |||||
3-Year Book Growth Rate | 11 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 71.09 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 13.83 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 87.92 | |||||
9-Day RSI | 86.09 | |||||
14-Day RSI | 82.39 | |||||
3-1 Month Momentum % | 47.35 | |||||
6-1 Month Momentum % | 46.35 | |||||
12-1 Month Momentum % | 49.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 1.35 | |||||
Cash Ratio | 0.64 | |||||
Days Sales Outstanding | 37.53 | |||||
Days Payable | 13.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | -18.39 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 10.66 | |||||
Operating Margin % | 2.45 | |||||
Net Margin % | 0.86 | |||||
EBITDA Margin % | 4.62 | |||||
FCF Margin % | 4.4 | |||||
OCF Margin % | 4.71 | |||||
ROE % | 3.91 | |||||
ROA % | 1.58 | |||||
ROIC % | 3.61 | |||||
3-Year ROIIC % | -0.65 | |||||
ROC (Joel Greenblatt) % | 144.97 | |||||
ROCE % | 8 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 80.61 | |||||
Forward PE Ratio | 38.72 | |||||
PE Ratio without NRI | 32.93 | |||||
Shiller PE Ratio | 103.32 | |||||
Price-to-Owner-Earnings | 24.87 | |||||
PEG Ratio | 1.46 | |||||
PS Ratio | 0.69 | |||||
PB Ratio | 3.01 | |||||
Price-to-Free-Cash-Flow | 15.63 | |||||
Price-to-Operating-Cash-Flow | 14.6 | |||||
EV-to-EBIT | 25.84 | |||||
EV-to-Forward-EBIT | 9.79 | |||||
EV-to-EBITDA | 17.21 | |||||
EV-to-Forward-EBITDA | 8.16 | |||||
EV-to-Revenue | 0.79 | |||||
EV-to-Forward-Revenue | 0.66 | |||||
EV-to-FCF | 18.08 | |||||
Price-to-GF-Value | 0.59 | |||||
Price-to-Projected-FCF | 1.91 | |||||
Price-to-Median-PS-Value | 0.57 | |||||
Earnings Yield (Greenblatt) % | 3.87 | |||||
FCF Yield % | 6.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ASTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Astrana Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3,526.482 | ||
| EPS (TTM) ($) | 0.61 | ||
| Beta | 1.0766 | ||
| 3-Year Sharpe Ratio | 0.32 | ||
| 3-Year Sortino Ratio | 0.52 | ||
| Volatility % | 68.83 | ||
| 14-Day RSI | 82.39 | ||
| 14-Day ATR ($) | 1.875361 | ||
| 20-Day SMA ($) | 41.265 | ||
| 12-1 Month Momentum % | 49.74 | ||
| 52-Week Range ($) | 18.08 - 51.6 | ||
| Shares Outstanding (Mil) | 49.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Astrana Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Astrana Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 17:30 | In 125 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 124 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 17:30 | In 34 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 33 days | ||
| General meeting for 2026 | 2026-06-10 10:00 | 38.29 (-0.85%) | ||
| 46th annual william blair growth stock conference | 2026-06-03 16:00 | 36.91 (-1.89%) | ||
| Guidance call for 2026 | 2026-05-12 18:40 | 37.97 (-3.80%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 17:30 | 35.25 (+0.66%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 35.25 (+0.66%) | ||
| Oppenheimer 36th Annual MedTech & Services Conference | 2026-03-18 | 24.80 (+0.81%) |
Show
Entries
Astrana Health Inc Frequently Asked Questions
What is Astrana Health Inc(ASTH)'s stock price today?
The current price of ASTH is $49.17. The 52 week high of ASTH is $51.60 and 52 week low is $18.08.
When is next earnings date of Astrana Health Inc(ASTH)?
The next earnings date of Astrana Health Inc(ASTH) is 2026-08-07 Est..
Does Astrana Health Inc(ASTH) pay dividends? If so, how much?
Astrana Health Inc(ASTH) does not pay dividend.
Guru Commentaries on NAS:ASTH
No articles.
Press Release
Articles on Astrana Health Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers